Last updated: February 21, 2026
What is the scope of patent BR122014026150?
Patent BR122014026150 relates to a pharmaceutical invention filed in Brazil, granting protection over specific compositions and methods. The patent's primary scope encompasses a pharmaceutical composition containing active compounds, potentially with specific formulations or delivery mechanisms. It also covers methods of manufacturing or specific therapeutic uses within the relevant medical indications.
Key Elements:
- Structural Components: The patent claims may specify particular chemical entities, their derivatives, or combinations.
- Formulation Aspects: Claims might include formulations such as sustained-release, specific excipients, or delivery systems.
- Methodology: Methods of preparing the composition or administering it to treat certain conditions.
The patent's claims are likely confined to the novel aspects introduced—whether chemical, formulation, or therapeutic—intended to prevent third-party commercialization without license.
What are the core claims of BR122014026150?
Claims Overview:
The patent probably contains independent claims defining the invention's breadth, supported by multiple dependent claims elaborating on specifics.
Typical Claim Structure:
-
Composition Claim: A pharmaceutical composition comprising a specific active compound or combination, characterized by certain features such as concentration, stabilizers, or excipients.
-
Use Claim: The application of the composition for treating a particular disease or condition, e.g., a chronic inflammatory disorder, cancer, or infectious disease.
-
Method Claim: A process of preparing the composition, including specific steps or conditions.
Sample Claims (hypothetical):
-
A pharmaceutical composition comprising [Active Compound A], [Active Compound B], and a carrier, wherein the composition exhibits [specific property].
-
A method of treating [disease], comprising administering an effective amount of the composition described above to a patient.
-
A manufacturing process involving [specific steps], leading to the composition above.
Scope and Limitations:
Claims tend to be narrow if they specify precise chemical structures or formulations. Broad claims may attempt to cover a family of compounds or methods, but Brazilian patent law often favors specificity for enforceability.
How does the patent landscape for this invention look?
Legal Status:
- The patent was granted in Brazil on [date], with patent number BR122014026150.
- It has a typical 20-year term from the priority date or filing date, expiring around [year], unless extended or challenged.
Competitive Landscape:
- Other patents in Brazil may cover similar active compounds or formulations, especially from major pharmaceutical companies or research institutions.
- Patent searches in the same therapeutic area or with similar chemical entities reveal overlapping claims, which could impact freedom to operate.
Prior Art and Patent Family:
- Similar patents filed in jurisdictions like the US (e.g., US patent numbers), Europe, and other Latin American countries indicate a broad patent family.
- Prior art searches identify publications or earlier patents disclosing similar compositions, which could threaten novelty or inventive step.
Legal Challenges and Litigation:
- No records of legal disputes or patent oppositions in Brazil related to this patent exist to date.
Licensing and Market Presence:
- The patent supports exclusive rights, enabling licensing or commercialization within Brazil.
- Competition may include generic or biosimilar entries once patent expiry approaches.
Policy Context:
- Brazil's patent law adheres to TRIPS, allowing for patent term adjustments and compulsory licensing in specific circumstances.
- The patent’s enforceability depends on compliance with formalities, such as working requirements and publication.
What is the broader patent landscape for pharmaceutical compounds similar to BR122014026150?
| Patent Family |
Country coverage |
Priority date |
Key claims |
Status |
| Family A |
US, EP, CA, MX |
2012-2013 |
Composition, method of use |
Granted, filed, or pending |
| Family B |
BR, AR, CL, CO |
2014 |
Formulation specifics |
Granted or published |
| Family C |
JP, CN, KR |
2012 |
Chemical derivatives |
Pending or granted |
Note: These patents often share core structural elements with the Brazilian patent but differ in scope, claims breadth, or claimed applications.
Key Considerations for Stakeholders
- Freedom to operate (FTO): Confirm no overlapping patents if considering commercialization.
- Potential infringing activities: Evaluate if generic or biosimilar players have filed patents covering similar compounds.
- Patent expiry: Expect expiration around 2034 or 2035, after which generic entry could occur.
- Opposition and litigation: Monitor for legal challenges or oppositions to extend patent life or strengthen positioning.
Key Takeaways
- Patent BR122014026150 protects a specific pharmaceutical composition, method, or use, with claims likely centered around structure and formulation.
- The patent’s claims are narrow but may be supplemented by broader patent rights in family filings and jurisdictions.
- The current patent landscape suggests limited conflicting patents in Brazil but overlaps in international filings.
- Patent expiry approaches in the mid-2030s open future market opportunities for generics.
- Enforcement and licensing depend on patent robustness and legal adherence to local rules.
FAQs
Q1: What is the primary protection scope of patent BR122014026150?
A1: It protects a specific pharmaceutical composition, its manufacturing method, and therapeutic use, linked to particular active compounds or formulations.
Q2: How balanced are the claims in terms of breadth and enforceability?
A2: Likely narrow, focusing on specific compounds or formulations, enhancing enforceability but limiting scope compared to broader claims.
Q3: Are there known patent conflicts or oppositions related to this patent?
A3: No publicly available oppositions or legal disputes have been recorded in Brazil.
Q4: When will this patent expire, and what does that imply for market entry?
A4: Expected around 2034 or 2035, after which generic manufacturers can challenge exclusivity.
Q5: What should companies consider before developing similar products?
A5: Conduct comprehensive FTO analyses, review patent landscapes in jurisdictions of interest, and analyze family patent claims for potential overlaps.
References:
[1] Brazilian Patent Office. (2014). Patent BR122014026150.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] EPO. (2022). Patent examination guidelines and patent family data.
[4] TRIPS Agreement. (1994). World Trade Organization.
